NCT03351751View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 8, 2017

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Placebo

Placebo

DRUG

PF-06372865

PF-06372865

Trial Locations (1)

06511

Pfizer New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03351751 - A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects | Biotech Hunter | Biotech Hunter